Search Results 41-50 of 17028 for IBS

  1. Lubiprostone (oral route) - Mayo Clinic

    For irritable bowel syndrome (IBS):. Adults—8 micrograms (mcg) two times a day (once in the morning and once in the evening) with food and water. Children ...

  2. Analyzing IBS to Identify Biomarkers and Microbiome Signatures - Mayo Clinic

    About this study. Microbiota from fecal samples from IBS-D patients, in combination with vitamin D supplementation added to our 3-D immunocompetent ...

  3. Identifying diarrhea caused by bile acid malabsorption - Mayo Clinic

    Studies have demonstrated that BAM occurs in about one-third of patients diagnosed with irritable bowel syndrome with diarrhea (IBS ... IBS-D. A clinical ...

  4. Obesity and IBS as likely associated comorbidities - Mayo Clinic

    This study will evaluate obesity as a comorbidity in a population of patients with irritable bowel syndrome (IBS), and assess this cohort for vitamin D- ...

  5. IBD and IBS/Treadmill Test/Weight-Loss Maintenance: Mayo Clinic Radio

    Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two very different chronic digestive system conditions that are sometimes confused with ...

  6. Tuesday Q & A: Stomach pain common in children, but exact source not always easy to identify - Mayo Clinic News Network

    If no other specific medical condition can be found, irritable bowel syndrome, or IBS, could be considered. IBS affects the intestine and often causes ...

  7. Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) - Mayo Clinic

    The purpose of this study is to compare the effects of 5g of TU-100 three times per day (TU-100 is a botanical agent that modulates gastrointestinal nerves), ...

  8. Linaclotide (oral route) - Mayo Clinic

    Linaclotide is used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It works by increasing intestinal ...

  9. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome · Share · Facebook · Twitter.

  10. Nonpharmacological approaches to management of functional gastrointestinal disorders — Where are we now? - Mayo Clinic

    Irritable bowel syndrome (IBS) is one of the most common forms of FGIDs and is estimated to affect 1 out of 7 adults in the United States. ... There are three ...